Lakefront Biotherapeutics (GLPGF) Share-based Compensation Growth (1y) (2017 - 2020)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Share-based Compensation Growth (1y) (2017 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 19.90% |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 2.67% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 71.86% |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | -3.46% |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | -7.69% |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | -22.43% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 3.34% |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 177.31% |
| Mar 31, 2020 | 49.36% |
| Dec 31, 2019 | 12.63% |
| Sep 30, 2019 | 45.88% |
| Jun 30, 2019 | 53.44% |
| Mar 31, 2019 | 40.79% |
| Dec 31, 2018 | 180.78% |
| Sep 30, 2018 | 100.11% |
| Jun 30, 2018 | -99.90% |
| Mar 31, 2018 | 50.40% |
| Jun 30, 2017 | 289,559.74% |
| Mar 31, 2017 | 53.52% |